SCHEMBL884632

SCHEMBL884632

Nc1ccc(Nc2ccccc2CC(c2cccnc2)c2cccnc2)nc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 14/20 0.49
KCNH2 Q12809 5/20 0.49
CFTR P13569 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
GOPC Q9HD26 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL885040 0.86 KCNA5 (0.46) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL884625 0.85 KCNA5 (0.53) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL884592 0.83 KCNA5 (0.46) KCNA5KCNH2SMN1; SMN2TSHR
SCHEMBL884872 0.83 KCNA5 (0.53) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL885079 0.80 KCNA5 (0.56) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL884575 0.79 KCNA5 (0.52) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL884331 0.79 KCNA5 (0.49) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL884862 0.78 KCNA5 (0.57) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL884337 0.77 KCNA5 (0.60) KCNA5KCNH2CFTRSLC6A2SLC6A4
SCHEMBL2062493 0.75 KCNA5 (0.50) KCNA5KCNH2CFTRSLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940406-A2 POTASSIUM CHANNEL INHIBITORS Merck and Co., Inc. (US) 2008-07-09 EP claimed
WO-2007050348-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2007-05-03 WO claimed
EP-1940406-A2 POTASSIUM CHANNEL INHIBITORS Merck and Co., Inc. (US) 2008-07-09 EP disclosed
WO-2007050348-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2007-05-03 WO disclosed